1.12
前日終値:
$1.135
開ける:
$1.14
24時間の取引高:
22,191
Relative Volume:
0.13
時価総額:
$49.87M
収益:
$63.15M
当期純損益:
$-40.30M
株価収益率:
-0.6707
EPS:
-1.67
ネットキャッシュフロー:
$-44.47M
1週間 パフォーマンス:
-5.93%
1か月 パフォーマンス:
-3.48%
6か月 パフォーマンス:
-42.49%
1年 パフォーマンス:
-60.78%
Tela Bio Inc Stock (TELA) Company Profile
名前
Tela Bio Inc
セクター
電話
484-320-2930
住所
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
TELA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
TELA
Tela Bio Inc
|
1.12 | 50.54M | 63.15M | -40.30M | -44.47M | -1.67 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.67 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.76 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.85 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-03-21 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | 開始されました | Lake Street | Buy |
| 2019-12-03 | 開始されました | Canaccord Genuity | Buy |
| 2019-12-03 | 開始されました | JMP Securities | Mkt Outperform |
| 2019-12-03 | 開始されました | Jefferies | Buy |
| 2019-12-03 | 開始されました | Piper Jaffray | Overweight |
すべてを表示
Tela Bio Inc (TELA) 最新ニュース
TELA Bio introduces LIQUIFIX for enhanced surgical precision - Traders Union
Is TELA Bio Inc. stock in correction or buying zone2026 world cup usa national team round of 32 young talents transition play winner prediction breakdown - ulpravda.ru
TELA Bio to Present at Canaccord Genuity 45th Annual Growth Conference - MSN
TELA Bio Appoints Healthcare Leader Betty Jo Rocchio to Board of Directors - MSN
Is It Too Late to Sell PVV Infra LimitedLong-Term Investment Plans & Outstanding Wealth Building - earlytimes.in
TELA Bio Inc Stock Analysis and ForecastVolatility Trading Techniques & Minimal Investment Profits - earlytimes.in
Movement Recap: How TELA Bio Inc stock reacts to bond yieldsJuly 2025 Sector Moves & Long-Term Safe Investment Ideas - moha.gov.vn
Small Medtech TELA Bio Takes On Becton Dickinson, Alleges Hernia Mesh Monopoly - Benzinga
Becton, Dickinson accused of hindering competition in hernia mesh market - MSN
Becton Muscles Out Hernia Mesh Rivals, Antitrust Suit Says - Law360
Tela Bio (TELA) Sues Becton, Dickinson Over Hernia Mesh Market P - GuruFocus
Medical device maker Becton Dickinson sued over alleged hernia mesh monopoly - Reuters
Is TELA Bio Inc. stock a top pick in earnings seasonWeekly Market Outlook & Smart Swing Trading Techniques - Улправда
How sustainable is TELA Bio Inc. stock dividend payoutQuarterly Portfolio Summary & Growth Focused Entry Point Reports - Улправда
Will TELA Bio Inc. stock continue dividend increasesWeekly Trading Summary & Reliable Breakout Stock Forecasts - Улправда
How TELA Bio Inc. stock reacts to bond yields2025 Bull vs Bear & Weekly Momentum Stock Picks - DonanımHaber
Becton Dickinson Faces Antitrust Suit Over Hernia Mesh Products - Bloomberg Law News
Whale Trades: Is TELA Bio Inc. stock a top pick in earnings seasonMarket Growth Review & Daily Stock Trend Watchlist - Улправда
Update Report: Is TELA Bio Inc. stock gaining market shareJuly 2025 Opening Moves & Safe Entry Momentum Tips - ulpravda.ru
TELA Bio signals growth with new-hire equity grants - MSN
Is TELA Bio Inc. stock gaining market shareTrade Volume Report & Risk Managed Investment Signals - Улправда
Canaccord Genuity Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
TELA Bio Signals Growth With New-Hire Equity Grants - MyChesCo
TELA Bio Earnings Notes - Trefis
TELA Bio (TELA) price target decreased by 25.81% to 3.52 - MSN
Lake Street Keeps Their Buy Rating on TELA Bio (TELA) - The Globe and Mail
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Associated Press | syndication news - Enidnews.com
What analysts say about TELA Bio Inc stockTrading Volume Surges & High Return Capital Growth - earlytimes.in
TELA Bio, Inc. (NASDAQ:TELA) Receives $3.25 Consensus Price Target from Analysts - Defense World
Resistance Check: Is TELA Bio Inc stock gaining market shareMarket Performance Summary & Entry Point Strategy Guides - BỘ NỘI VỤ
TELA Bio (TELA) Stock Analysis Report | Financials & Insights - Benzinga
Analysts Offer Insights on Healthcare Companies: TELA Bio (TELA) and Centessa Pharmaceuticals (CNTA) - The Globe and Mail
TELA Bio stock price target lowered to $3 by Lake Street on sales issues - Investing.com South Africa
Lake Street Maintains TELA Bio (TELA) Buy Recommendation - Nasdaq
Lake Street Lowers Price Target for TELA Bio (TELA) Amid Continued Buy Rating | TELA Stock News - GuruFocus
TELA Bio, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Financial Performance - Markets Mojo
TELA Bio Set to Spotlight Soft-Tissue Innovations at Major Healthcare Conference - MSN
TELA Bio Unveils New Wave of Hiring With Stock Grants Tied to Growth Push - MSN
TELA Bio Posts Steady Growth as Strategic Shift Sparks New Commercial Momentum - MSN
Goodwin Advises TELA Bio On $13 Million Underwritten Registered Direct Offering And Credit Refinancing - Mondaq
How to track smart money flows in TELA Bio Inc.2025 AllTime Highs & Consistent Return Strategy Ideas - newser.com
What MACD signals say about TELA Bio Inc.July 2025 Setups & Weekly High Return Forecasts - newser.com
Measuring TELA Bio Inc.’s beta against major indicesPortfolio Value Summary & High Accuracy Trade Signal Alerts - newser.com
Tela Bio Inc (TELA) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):